“In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam,” Boston Scientific stated in an Aug. 4 quarterly filing. “The company is cooperating with government agencies while investigating these allegations.”
The company has not provided any further details beyond that, such as which government agencies are investigating it or what the specific FCPA violations entailed. 
Jaclyn Jaeger is a contributing editor at Compliance Chief 360° and a freelance business writer based in Manchester, New Hampshire.